Stay updated on PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial
Sign up to get notified when there's something new on the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page.

Latest updates to the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no changes to the study details content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe only observed change is the revision label updated from v3.4.1 to v3.4.2; all other content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page shows a minor version update from v3.4.0 to v3.4.1 with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision tag changed from v3.3.3 to v3.3.4, a minor metadata update that does not affect content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded a dedicated Locations section showing Dallas, Texas as a study site. The footer entries for HHS Vulnerability Disclosure and Texas Locations were removed, and the page revision is now v3.3.3.SummaryDifference0.2%

Stay in the know with updates to PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page.